Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 545-551

  Hu, De En ^a   Hiley, C Robin ^a   Fan, Tai Ping D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Angiogenesis; Angotensin II; Endothelin 1; Endothelin 3; Interleukin 1 ; Losartan; Vasoactive intestinal peptide VIP

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ENDOTHELIN 1; ENDOTHELIN 3; INTERLEUKIN 1ALPHA; LOSARTAN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE[10-28]; XENON 133;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; HISTOLOGY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SPONGE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030022427     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15225.x     Document Type: Article

References (63)

1. ANDRADE, S.P., FAN, T.-P.D. & LEWIS, G.P. (1987). Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br. J. Exp. Pathol., 68, 755-766.
2. ARAI, K., LEE, F., MIYAJIMA, A., MIYATAKE, S., ARAI, N. & YOKOTA, T. (1990). Cytokines: coordinators of immune and inflammatory responses. Ann. Rev. Biochem., 59, 783-836.
3. BEPLER, G., ROTSCH, M., JAQUES, G., HAEDER, M., HEYMANNS, J., HARTOGH, G., KIEFER, P. & HAVEMANN, K. (1988). Peptides and growth factors in small cell lung cancer: production, binding sites and growth effects. J. Cancer Res. Clin. Oncol., 114, 235-244.
4. BUCKLEY, T.L., BRAIN, S.D., COLLINS, P.D. & WILLIAMS, T.J. (1991). Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J. Immunol., 146, 3424-3430.
5. CARLINI, R.G., DUSSO, A.S., OBIALO, C.I., ALVAREZ, U.M. & ROTHSTEIN, M. (1993). Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int., 43, 1010-1014.
6. CARLINI, R.G., REYES, A.A. & ROTHSTEIN, M. (1995). Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int., 47, 740-745.
7. CUTZ, E., CHAN, W., TRACK, N.S., GOTH, A. & SAID, S.I. (1978). Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature, 275, 661-662.
8. 125I]-ET-1 binding to the atherosclerotic human coronary artery. Br. J. Pharmacol., 112, 386-389.
9. DINARELLO, C. A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood, 77, 1627-1652.
10. DOUGLAS, S.A. & HILEY, C.R. (1990). Endothelium-dependent vascular activities of endothelin-like peptides in the isolated superior mesenteric arterial bed of the rat. Br. J. Pharmacol., 101, 81-88.
11. DOUGLAS, S.A. & HILEY, C.R. (1991). Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptide in the rat. Br. J. Pharmacol., 104, 311-320.
12. ECONOMOS, K., MACDONALD, P.C. & CASEY, M.L. (1992). Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells. Cancer Res., 52, 554-557.
13. ESTIVAL, A., MOUNIELOU, P. & TROCHERIS, V. (1983). Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. Biochem. Biophys. Res. Commun., 111, 958-963.
14. FAN, T.-P.D. & BREM, S. (1992). Angiosuppression. In The Search for New Anti-Cancer Drugs. Cancer Biology & Medicine Series Vol. 3 ed. Waring, M.J. & Ponder, B.A.J., pp. 185-229. Dordrecht/ Boston/London: Kluwer Academic Publishers.
15. 1 or interleukin-1 receptor antagonists. Br. J. Pharmacol., 110, 43-49.
16. FAN, T.-P.D., JAGGAR, R. & BICKNELL, R. (1995). Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol. Sci., 16, 57-66.
17. FERNANDEZ, L.A., CARIDE, V.J., TWICKLER, J. & GALARDY, R.E. (1982). Renin-angiotensin and development of collateral circulation after renal ischemia. Am. J. Physiol., 243, H869-H875.
18. FERNANDEZ, L.A., TWICKLER, J. & MEAD, A. (1985). Neovascularization produced by angiotensin II. J. Lab. Clin. Med., 105, 141-145.
19. FOLKMAN, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med., 1, 27-31.
20. FOLKMAN, J. & SHING, Y. (1992). Angiogenesis. J. Biol. Chem., 267, 10931-10934.
21. HAEGERSTRAND, A., JONZON, B., DALSGAARD, C.J., & NILSSON, J. (1989). Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes. Proc. Natl. Acad. Sci. U.S.A., 86, 5993-5996.
22. HAHN, A.W., RESINK, T.J., KERN, F. & BÜHLER, F.R. (1993). Peptide vasoconstrictors, vessel structure, and vascular smooth muscle proliferation. J. Cardiovasc. Pharmacol., 22 (Suppl. 5), S37-S43.
23. HATTORI, Y., NAGASHIMA, M., ENDO, Y. & KANNO, M. (1992). Glibenclamide does not block arterial relaxation caused by vasoactive intestinal polypeptide. Eur. J. Pharmacol., 213, 147-150.
24. HIRATA, Y., TAKAGI, Y., FUKUDA, Y. & MARUMO, F. (1989). Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis, 78, 225-228.
25. 9-bradykinin inhibits the synergistic interaction between bradykinin and interleukin-1 in angiogenesis. Br. J. Pharmacol., 109, 14-17.
26. HU, D.-E. & FAN, T.-P.D. (1995a). Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor lavendustin A. Br. J. Pharmacol., 114, 262-268.
27. HU, D.-E. & FAN, T.-P.D. (1995b). The protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat. Inflammation, 19, 39-54.
28. 133Xc clearance, blood flow and histology in the rat sponge model for angiogenesis: further studies with angiogenic modifiers. Lab. Invest., 72, 601-610.
29. HU, D.-E., HORI, Y. & FAN, T.-P.D. (1993). Interleukin 8 stimulates angiogenesis in rats. Inflammation, 17, 135-143.
30. HU, D.-E., HORI, Y., PRESTA, M., GRESHAM, G.A & FAN, T.-P.D. (1994). Inhibition of angiogenesis by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation, 18, 45-58.
31. KIMURA, B., SUMNERS, C. & PHILLIPS, M.I. (1992). Changes in skin angiotensin II receptors in rats during wound healing. Biochem. Biophys. Res. Commun., 187, 1083-1090.
32. KOMURO, I., KURIHARA, H., SUGIYAMA, T., TAKAKU, F. & YAZAKI, Y. (1988). Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett., 238, 249-252.
33. KRAMER, B.K. NISHIDA, M., KELLY, R.A. & SMITH, T.W. (1992). Endothelins: myocardial actions of a new class of cytokines. Circulation, 85, 350-356.
34. LE NOBLE, F.A.C., HEKKING, J.W.M., VAN STRAATEN, H.W.M., SLAAF, D.W. & STRUIJKER BOUDIER, H.A.J. (1991). Angiotensin II stimulates angiogenesis in the chorioallantoic membrane of the chick embryo. Eur. J. Pharmacol., 195, 305-306.
35. LE NOBLE, F.A.C., SCHREURS, N.H.J.S., VAN STRAATEN, H.W.M., SLAFF, D.W., SMITS, J.F.M., ROGG, H. & STRUIJKER BOUDIER, H.A.J. (1993). Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am. J. Physiol., 264, R460-R465.
36. MOGHADDAM, A., ZHANG, H.T., FAN, T.-P.D., HU, D.-E., LEES, V.C., TURLEY, H., FOX, S.B., GATTER, K.V., HARRIS, A.L. & BICKNELL, R. (1995). Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. U.S.A., 92, 998-1002.
37. MUEGGE, K. & DURUM, S.K. (1990). Cytokines and transcription factors. Cytokine, 2, 1-8.
38. O'DORISIO, M.S., WOOD, C.L. & O'DORISIO, T.M. (1985). Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J. Immunol., 135, (Suppl.), 792S-796S.
39. PINCUS, D.W., DICICCO-BLOOM, E.M. & BLACK, I.B. (1990). Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature, 343, 564-567.
40. 1 receptor subtype. Circ. Res., 73, 413-423.
41. SAID, S.I. (1984). Vasoactive intestinal polypeptide (VIP): current status. Peptides, 5, 143-150.
42. SAID, S.I. & FALOONA, G.R. (1975). Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N. Engl. J. Med., 293, 155-160.
43. SAID, S.I. & MUTT, V. (1970). Potent peripheral and splanchnic vasodilator from normal gut. Nature, 225, 863-864.
44. SAKLATVALA, J., RAWLINSON, L.M., MARSHALL, C.J. & KRACHT, M. (1993). Interleukin-1 and tumour necrosis factor activate the mitogen activated protein (MAP) kinase kinase in cultured cells. FEBS Lett., 334, 189-192.
45. SERRADEIL-LE GAL, C., HERBERT, J.M., GARCIA, C., BOUTIN, M. & MAFFRAND, J.P. (1991). Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin. Peptides, 12, 575-579.
46. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest., 95, 651-657.
47. TAKAHASHI, K., NAKANISHI, S. & IMAMURA, S. (1993). Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocytc cell line: Stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J. Invest. Dermatol., 101, 646-651.
48. TIMMERMANS, P.B.M.W.M., WONG, P.C., CHIU, A.T., HERBLIN, W.F., BENFIELD, P., CARINI, D.J., LEE, R.J., WEXLER, R.R., SAYE, J.A.M. & SMITH, R.D. (1993). Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev., 45, 205-251.
49. TSUDA, T., KAWAHARA, Y., SHII, K., KOIDE, M., ISHIDA, Y. & YOKOYAMA, M. (1991). Vasoconstrictor-induced protein-tyrosine phosphorylation in cultured vascular smooth muscle cells. FEBS Lett., 285, 44-48.
50. TURNER, J.T., JONES, S.B. & BYLUND, D.B. (1986). A fragment of vasoactive intestinal peptide, VIP (10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Peptides, 7, 849-854.
51. VIGNE, P., MARSAULT, R., BREITTMAYER, J.P. & FRELIN, C. (1990). Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem. J., 266, 415-420.
52. VIRGOLINI, I., RADERER, M., KURTARAN, A., ANGELBERGER, P., BANYAI, S., YANG, Q., LI, S., BAYYAI, M., PIDLICH, J., NIEDERLE, B., SCHEITHAUER, W. & VALENT, P. (1994). Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med., 331, 1116-1121.
53. WARNER, T.D., DE NUCCI, G. & VANE, J.R. (1989). Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol., 159, 325-326.
54. WASCHEK, J.A. (1995). Vasoactive intestinal peptide: an important trophic factor and developmental regulator? Dev. Neurosci., 17, 1-7.
55. WEBER, H., TAYLOR, D.S. & MOLLOY, C.J. (1994a). Angiotensin H induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific endogenous growth factors and reversal by suramin. J. Clin. Invent., 93, 788-798.
56. WEBER, H., WEBB, M.L., SERAFINO, R., TAYLOR, D.S., MORELAND, S., NORMAN, J. & MOLLOY, C.J. (1994b). Endothelin-1 and angiotensin II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol. Endocrinol., 8, 148-158.
57. WOLL, P.J. (1991). Neuropeptide growth factors and cancer. Br. J. Cancer, 63, 469-475.
58. WREN, A.D., HILEY, C.R. & FAN, T.-P.D. (1993). Endothelin-3 mediated proliferation in wounded human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun., 196, 369-375.
59. WRIGHT, C.E. & FOZARD, J.R. (1988). Regional vasodilation is a prominent feature of the haemodynamic response to endothelia in anaesthetized, spontaneously hypertensive rats. Eur. J. Pharmacol., 155, 201-203.
60. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
61. YU, S., YU, C., WONG, H. & YUAN, H. (1991). Effect of endothelin-1 on the vascular smooth muscle cell cycle. J. Cardiovasc. Pharmacol., 17, (Suppl. 7), S239-S241.
62. ZACHARY, L., WOLL, P.J. & ROZENGURT, E. (1987). A role for neuropeptides in the control of cell proliferation. Dev. Biol., 124, 295-308.
63. 2+ and protein kinase C. Exp. Cell Res., 176, 155-161.